期刊文献+

P53蛋白过表达和P53基因突变与胶质母细胞瘤预后关系的Meta分析 被引量:9

P53 overexpression and P53 mutations in the prognosis of glioblastoma: A Meta-analysis
下载PDF
导出
摘要 目的胶质母细胞瘤(glioblastoma,GBM)是常见的颅内恶性肿瘤,预后不良。寻找与胶质母细胞瘤预后的相关因素对提高患者生存率有重大意义。P53异常是与肿瘤发生发展有关的重要因素。文中探讨P53蛋白过表达和P53基因突变对GBM预后的影响。方法应用Meta分析对有关P53蛋白过表达和P53基因突变与GBM预后相关的文献进行综合分析。结果纳入的文献中研究P53蛋白过表达与GBM预后关系的文献6篇,累计病例539例,阳性率53.4%;P53基因突变与GBM预后关系的文献7篇,累计病例514例,阳性(与预后不良有关)率25.3%。P53过表达和P53突变与GBM预后的合并相对危险度(relative hazard,RH)分别为0.95和0.61,95%可信区间分别为0.85~1.08和0.51~0.73,P值分别为0.829和0.000。结论根据所纳入的文献进行Meta分析结果提示P53蛋白过表达与GBM预后无关,而P53基因突变是GBM预后良好的生物学标志物。 Objective Glioblastoma(GBM) is a common intracranial malignant tumor,and determination of certain prognostic factors is of great significance in improving the survival rate of the patients.P53 abnormity is an important factor in the development of tumors.The aim of this study was to investigate the correlation of P53 overexpression and P53 mutations with the prognosis of GBM.Methods We performed a meta-analysis on the literature relating the correlation of P53 overexpression and P53 mutations with the prognosis of GBM.Results A total of 13 trials were identified,including 6 on P53 overexpression in 539 patients,with a positive rate of 53.4%,and 7 on P53 mutations in 514 cases,with a positive rate of 25.3%.The combined relative hazard(RH) of P53 overexpression on the prognosis of GBM was 0.98(95%CI: 0.78-1.23,P=0.829),while that of P53 mutations on the prognosis of GBM was 0.62(95%CI: 0.53-0.73,P=0.000).Conclusion The Meta analyse result of the literatures collected showed that P53 mutation is a biomarker for good prognosis of GBM,while P53 overexpression is not correlated with it.
出处 《医学研究生学报》 CAS 2011年第2期163-167,共5页 Journal of Medical Postgraduates
基金 国家自然科学基金(30870689) 江苏省自然科学基金(BK2008325)
关键词 P53 胶质母细胞瘤 预后 META分析 P53 Glioblastoma Prognosis Meta-analysis
  • 相关文献

参考文献16

  • 1Tierney JF,Stewart LA,Ghersi D,et al.Practical methods for incorporating summary time-to-event data into meta-analysis[J].Trials,2007,8:16.
  • 2Li S,Zhang W,Chen B,et al.Prognostic and predictive value of p53 in low MGMT expressing glioblastoma treated with surgery,radiation and adjuvant temozolomide chemotherapy[J].Neurol Res,2010,32(7):690-694.
  • 3Umesh S,Tandon A,Santosh V,et al.Clinical and immunohistochemical prognostic factors in adult glioblastoma patients[J].Clin Neuropathol,2009,28(5):362-372.
  • 4Donato V,Papaleo A,Castrichino A,et al.Prognostic implication of clinical and pathologic features in patients with glioblastoma multiforme treated with concomitant radiation plus temozolomide[J].Tumori,2007,93(3):248-256.
  • 5Simmons ML,Lamborn KR,Takahashi M,et al.Analysis of complex relationships between age,p53,epidermal growth factor receptor,and survival in glioblastoma patients[J].Cancer Res,2001,61(3):1122-1128.
  • 6Korshunov A,Golanov A,Sycheva R,et al.Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas:an analysis of 168 cases[J].J Clin Pathol,1999,52(8):574-580.
  • 7Kyritsis AP,Bondy ML,Hess KR,et al.Prognostic significance of p53 immunorectivity in patients with glioma[J].Clin Cancer Res,1995,1(12):1617-1622.
  • 8Shih HA,Betensky RA,Dorfman MV,et al.Genetic analyses for predictors of radiation response in glioblastoma[J].Int J Radiat Oncol Biol Phys,2005,63(3):704-710.
  • 9Hill C,Hunter SB,Brat DJ.Genetic markers in glioblastoma:prognostic significance and future therapeutic implications[J].Adv Anat Pathol,2003,10(4):212-217.
  • 10Shiraishi S,Tada K,Nakamura H,et al.Influence of p53 mutations on prognosis of patients with glioblastoma[J].Cancer,2002,95(2):249-257.

二级参考文献41

  • 1葛京平,魏武,魏威,张征宇,高建平,马驰原.survivin在膀胱癌中的表达及其临床意义[J].医学研究生学报,2006,19(8):716-718. 被引量:9
  • 2陈书昌,陈建民,陈晔,李杏梅,洪安民.氩氦刀靶向冷冻联合化疗治疗中晚期非小细胞肺癌[J].山东医药,2007,47(15):56-57. 被引量:7
  • 3Parkin DM, Bray FI, Devesea SS . Cancer burden in the year 2000 the global picture [ J ]. Eur J cancer,2001, 37 ( Suppl ) : 44-66.
  • 4Deygas N, Froudarakis M, Ozenne G,et al. Cryotherapy in early superficial bronchogenic carcinoma [ J ]. Chest, 2001,120 ( 1 ) : 26 -31.
  • 5Asimakopulos G,Besson J,Evans J,et al. Cryosurgery for malignant endobronchial tumors [ J ]. Chest, 2005, 127 ( 6 ) : 2007- 2014.
  • 6Tanks S. Immunological aspects of cryosurgrry in general surgery [ J ]. Cryobiology, 1982,19 ( 3 ) :247-262.
  • 7张燕,安永辉,张富同,等.氩氦刀联合全身化疗治疗中、晚期非小细胞肺癌的临床研究.//第一届中国肿瘤靶向治疗技术大会论文集[C].三亚:中国生物医学工程学会,2003:161-168.
  • 8Allen PJ,D' Angelica M,Hodyl CT,et al. The effects of hepatic cryosurgery on tumor growth in the liver[ J ] . Surg Res, 1998,77 (2) :132-136.
  • 9Bertoletti L, Elleuch R, Kaeemarek D,et al. Bronchoscopic cryotherapy treatment of isolated endoluminal typical careinoid lumor [ J ]. Chest, 2006,130 ( 5 ) : 1405-1411.
  • 10Wang HW, Litter P, Duan YY,et al. Thoracic masses treated with percutaneous Cryotherapy:initial experience with more than 200 proeedures[J]. Radiology, 2005,1 ( 235 ) : 289-298.

共引文献23

同被引文献117

引证文献9

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部